ARK Investment Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.3M Sell
1,715,040
-293,440
-15% -$3.82M 0.16% 69
2025
Q1
$21.3M Buy
2,008,480
+74,629
+4% +$790K 0.21% 63
2024
Q4
$32.8M Sell
1,933,851
-167,187
-8% -$2.84M 0.27% 55
2024
Q3
$48.8M Buy
2,101,038
+136,074
+7% +$3.16M 0.45% 44
2024
Q2
$47.8M Buy
1,964,964
+275,315
+16% +$6.7M 0.42% 39
2024
Q1
$57.1M Sell
1,689,649
-358,038
-17% -$12.1M 0.4% 47
2023
Q4
$64.6M Buy
2,047,687
+146,141
+8% +$4.61M 0.38% 40
2023
Q3
$48.6M Sell
1,901,546
-5,450
-0.3% -$139K 0.37% 40
2023
Q2
$54.7M Sell
1,906,996
-78,425
-4% -$2.25M 0.36% 39
2023
Q1
$47.6M Sell
1,985,421
-27,008
-1% -$647K 0.33% 42
2022
Q4
$34.1M Sell
2,012,429
-169,274
-8% -$2.87M 0.3% 48
2022
Q3
$32.3M Sell
2,181,703
-122,048
-5% -$1.81M 0.23% 57
2022
Q2
$45.8M Sell
2,303,751
-80,089
-3% -$1.59M 0.27% 59
2022
Q1
$64.3M Sell
2,383,840
-88,790
-4% -$2.39M 0.27% 59
2021
Q4
$91.5M Sell
2,472,630
-56,879
-2% -$2.11M 0.28% 61
2021
Q3
$121M Sell
2,529,509
-355,173
-12% -$17M 0.29% 62
2021
Q2
$97.6M Sell
2,884,682
-447,207
-13% -$15.1M 0.18% 90
2021
Q1
$138M Sell
3,331,889
-627,130
-16% -$25.9M 0.27% 77
2020
Q4
$172M Buy
3,959,019
+1,463,177
+59% +$63.5M 0.46% 56
2020
Q3
$107M Buy
2,495,842
+577,007
+30% +$24.8M 0.64% 43
2020
Q2
$89.7M Buy
1,918,835
+354,378
+23% +$16.6M 0.96% 29
2020
Q1
$21.3M Buy
1,564,457
+180,701
+13% +$2.46M 0.53% 38
2019
Q4
$15M Buy
1,383,756
+109,343
+9% +$1.19M 0.38% 45
2019
Q3
$13.1M Buy
1,274,413
+270,045
+27% +$2.77M 0.29% 53
2019
Q2
$9.48M Buy
1,004,368
+77,224
+8% +$729K 0.24% 55
2019
Q1
$6.33M Buy
927,144
+111,968
+14% +$765K 0.18% 62
2018
Q4
$3.69M Buy
815,176
+41,404
+5% +$188K 0.15% 68
2018
Q3
$6.84M Buy
773,772
+239,999
+45% +$2.12M 0.21% 64
2018
Q2
$4.53M Buy
533,773
+202,608
+61% +$1.72M 0.17% 66
2018
Q1
$1.82M Buy
331,165
+254,428
+332% +$1.4M 0.09% 90
2017
Q4
$610K Buy
+76,737
New +$610K 0.05% 112